Literature DB >> 24252057

Anatomical variations of donor portal vein in right lobe living donor liver transplantation: the safe use of variant portal veins.

Necdet Guler1, Murat Dayangac, Onur Yaprak, Murat Akyildiz, Yusuf Gunay, Fatih Taskesen, Babek Tabandeh, Fisun Bulutcu, Yildiray Yuzer, Yaman Tokat.   

Abstract

In right lobe (RL) living donor liver transplantation (LDLT), portal vein (PV) variations are of immense clinical significance. In this study, we describe in detail our PV reconstruction techniques in RL grafts with variant PV anatomy and evaluate the impact of accompanying biliary variations on the recipient outcomes. In a total of 386 RL LDLTs performed between July 2004 and July 2012, the clinical data on 52 (13%) transplants using RL grafts with variant PV anatomy were retrospectively analyzed. Portal vein anatomy was classified as type 2 in 20 patients, type 3 in 24 patients, and type 4 in eight patients. The PV reconstruction techniques utilized included back-wall plasty (n = 21), back-wall plasty with saphenous vein graft interposition (n = 6), saphenous vein graft interposition (n = 5), cryopreserved iliac vein Y-graft interposition (n = 6), and quiltplasty (n = 3). There was no donor mortality. In a median follow-up of 29 months, none of the recipients had vascular complications. Anomalous PV anatomy was associated with a high (54%) incidence of biliary variations; however, these variations did not result in increased biliary complication rate. Overall, the 1- and 3-year patient survival rates of recipients were 91% and 81%, respectively. Vascular and biliary variations in RL grafts render LDLT technically more challenging. By employing appropriate reconstruction techniques, it is possible to successfully use RL grafts with PV variations without endangering recipient and donor safety.
© 2013 Steunstichting ESOT. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  cryopreserved vein graft; hilar variations; live donor surgery; living donor liver transplantation; portal vein reconstruction; right lobe graft

Mesh:

Year:  2013        PMID: 24252057     DOI: 10.1111/tri.12190

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  6 in total

1.  Evaluating the living donor: expansion by innovation.

Authors:  Chung-Mau Lo
Journal:  Hepatol Int       Date:  2016-02-26       Impact factor: 6.047

2.  Biliary reconstructive techniques and associated anatomic variants in adult living donor liver transplantations: The adult-to-adult living donor liver transplantation cohort study experience.

Authors:  Talia B Baker; Michael A Zimmerman; Nathan P Goodrich; Benjamin Samstein; Elizabeth A Pomfret; James J Pomposelli; Brenda W Gillespie; Carl L Berg; Jean C Emond; Robert M Merion
Journal:  Liver Transpl       Date:  2017-12       Impact factor: 5.799

3.  Conjoined Unification Venoplasty for Double Portal Vein Branches of Right Liver Graft: 1-Year Experience at a High-Volume Living Donor Liver Transplantation Center.

Authors:  Shin Hwang; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Deok-Bog Moon; Chul-Soo Ahn; Ki-Hun Kim; Gil-Chun Park; Sung-Gyu Lee
Journal:  J Gastrointest Surg       Date:  2016-01       Impact factor: 3.452

4.  Adult to adult right lobe living donor liver transplantation: does biological relationship matter?

Authors:  Wei Zhang; Yifei Tan; Shu Shen; Li Jiang; Lunan Yan; Jiayin Yang; Bo Li; Tianfu Wen; Yong Zeng; WenTao Wang; Mingqing Xu
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

5.  Laparoscopic donor right hepatectomy in a donor with type III portal vein anomaly: A case report.

Authors:  Jiu-Lin Song; Hong Wu; Jia-Yin Yang
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

6.  Living liver donor hilar anatomical variations and impact of variant anatomy on transplant outcomes.

Authors:  Elvan Onur Kirimker; Meltem Kologlu; Suleyman Utku Celik; Evren Ustuner; Melahat Kul; Digdem Kuru Oz; Mehmet Kaan Karayalcin; Deniz Balci
Journal:  Medicine (Baltimore)       Date:  2022-09-16       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.